CSF1R and early-onset autosomal dominant Alzheimer disease: Indeed, CSF‐1R inhibitors have been shown to mitigate neuroinflammation, enhance the survival and proliferative capabilities of microglia, and impede the advancement of Alzheimer's disease in mouse models [42].